Cellular Effect
| Cell Line | Activity | Value | Description | Reference |
|---|---|---|---|---|
| CV-1 | EC50 | 0.704 μM | Agonist activity at human PPARgamma ligand binding domain expressed in african green monkey CV1 cells co-transfected with fused Gal4-DBD by transactivation assay | [PMID: 18826205] |
| CV-1 | EC50 | 3.124 μM | Agonist activity at human PPARalpha ligand binding domain expressed in african green monkey CV1 cells co-transfected with fused Gal4-DBD by transactivation assay | [PMID: 18826205] |
| HEK293 | EC50 | 0.36 μM | Agonist activity at GAL4N fused human PPARgamma LBD expressed in HEK293 cells co-expressing TK-MH100x4-Luc after 24 hrs by luciferase reporter gene assay | [PMID: 28539218] |
| HEK293 | EC50 | 3.8 μM | Agonist activity at GAL4N fused human PPARalpha LBD expressed in HEK293 cells co-expressing TK-MH100x4-Luc after 24 hrs by luciferase reporter gene assay | [PMID: 28539218] |
| HepG2 | EC50 | 0.013 μM | Agonist activity at human PPARgamma ligand binding domain expressed in human HepG2 cells co-transfected with PPRE3-TK-luc assessed as induction of beta-galactosidase activity by transactivation assay | [PMID: 18805005] |
| HepG2 | EC50 | 0.82 μM | Agonist activity at human PPARalpha ligand binding domain expressed in human HepG2 cells co-transfected with PPRE3-TK-luc assessed as induction of beta-galactosidase activity by transactivation assay | [PMID: 18805005] |
| HepG2 | EC50 | 3528 nM | Agonist activity at human PPARgamma in HepG2 cells by PPAR-GAL4 transactivation assay | [PMID: 17157019] |
| HepG2 | EC50 | 9798 nM | Agonist activity at human PPARalpha in HepG2 cells by PPAR-GAL4 transactivation assay | [PMID: 17157019] |